×
Innoviva SG&A Expenses 2010-2024 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
Innoviva SG&A Expenses 2010-2024 | INVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Innoviva sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$823.1B
Johnson & Johnson (JNJ)
$380.1B
Novo Nordisk (NVO)
$374.3B
AbbVie (ABBV)
$348.4B
Roche Holding AG (RHHBY)
$259.5B
Novartis AG (NVS)
$218.5B
Merck (MRK)
$216.5B
Pfizer (PFE)
$146.7B
Sanofi (SNY)
$136B
Bayer (BAYRY)
$22B